Personal tools

Coexpression cluster:C2723: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Coexpression_clusters
{
|coexpression_dpi_cluster_scores_median=0,

Latest revision as of 12:11, 17 September 2013


Full id: C2723_Pericytes_Meningeal_Smooth_Fibroblast_cerebellum_Hair_rhabdomyosarcoma



Phase1 CAGE Peaks

Hg19::chr3:147111231..147111281,+p3@ZIC1
Hg19::chr3:147111285..147111298,+p10@ZIC1
Hg19::chr3:147111317..147111328,+p8@ZIC1
Hg19::chr3:147131775..147131783,+p@chr3:147131775..147131783
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
central nervous system2.88e-5281
nervous system9.93e-5289
brain1.61e-4868
future brain1.61e-4868
neural tube8.49e-4056
neural rod8.49e-4056
future spinal cord8.49e-4056
neural keel8.49e-4056
regional part of nervous system1.36e-3653
regional part of brain1.36e-3653
neural plate5.71e-3282
presumptive neural plate5.71e-3282
neurectoderm1.28e-2986
ecto-epithelium1.39e-28104
ectoderm-derived structure1.82e-28171
ectoderm1.82e-28171
presumptive ectoderm1.82e-28171
regional part of forebrain9.51e-2441
forebrain9.51e-2441
anterior neural tube9.51e-2441
future forebrain9.51e-2441
structure with developmental contribution from neural crest8.95e-22132
pre-chordal neural plate2.00e-2161
telencephalon4.72e-1934
brain grey matter1.03e-1834
gray matter1.03e-1834
posterior neural tube5.01e-1815
chordal neural plate5.01e-1815
cerebral hemisphere2.88e-1732
regional part of telencephalon3.41e-1732
organ system subdivision5.56e-15223
segmental subdivision of hindbrain7.18e-1512
hindbrain7.18e-1512
presumptive hindbrain7.18e-1512
segmental subdivision of nervous system1.99e-1313
cerebral cortex5.45e-1325
pallium5.45e-1325
regional part of metencephalon1.25e-119
metencephalon1.25e-119
future metencephalon1.25e-119
regional part of cerebral cortex5.50e-1122
adult organism3.73e-10114
vasculature of organ4.27e-1011
cell layer1.73e-09309
neocortex1.80e-0920
skin of body2.70e-0941
cerebellum3.23e-096
rhombic lip3.23e-096
epithelium3.25e-08306
brain vasculature5.48e-085
articulation8.61e-088
skeletal joint8.61e-088
articular system8.61e-088
intervertebral cartilage1.22e-075
symphysis1.22e-075
nonsynovial joint1.22e-075
fibrous joint1.22e-075
cartilaginous joint1.22e-075
developing mesenchymal condensation1.22e-075
pre-cartilage condensation1.22e-075
cartilaginous condensation1.22e-075
cartilage element1.22e-075
post-cranial axial skeletal system1.22e-075
vertebral column1.22e-075
intervertebral disk1.22e-075
intervertebral joint1.22e-075
integument1.32e-0746
integumental system1.32e-0746
brainstem2.36e-076
neural nucleus2.53e-079
nucleus of brain2.53e-079
Disease
Ontology termp-valuen
musculoskeletal system disease4.19e-075
myotonic disease4.19e-075
muscle tissue disease4.19e-075
myopathy4.19e-075
muscular disease4.19e-075
myotonic dystrophy4.19e-075


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.720743
MA0004.10.71247
MA0006.10.532262
MA0007.10.6918
MA0009.11.20602
MA0014.10.244769
MA0017.10.577281
MA0019.10.873355
MA0024.11.09684
MA0025.11.34373
MA0027.12.83281
MA0028.10.550763
MA0029.11.11704
MA0030.11.10506
MA0031.11.03735
MA0038.10.824639
MA0040.11.12314
MA0041.10.732902
MA0042.10.697662
MA0043.11.20635
MA0046.11.19471
MA0048.10.25531
MA0050.11.66718
MA0051.10.820063
MA0052.11.12718
MA0055.10.791759
MA0056.10
MA0057.13.6449
MA0058.10.605914
MA0059.10.604454
MA0060.10.393285
MA0061.10.360128
MA0063.10
MA0066.10.825101
MA0067.11.53181
MA0068.10.313194
MA0069.11.19071
MA0070.11.17908
MA0071.10.782546
MA0072.11.1744
MA0073.119.8761
MA0074.10.819248
MA0076.10.623864
MA0077.11.16637
MA0078.10.926725
MA0081.10.604638
MA0083.11.21381
MA0084.11.72172
MA0087.11.17185
MA0088.10.536981
MA0089.10
MA0090.10.640115
MA0091.10.715356
MA0092.10.673508
MA0093.10.535768
MA0095.10
MA0098.10
MA0100.10.83965
MA0101.10.539569
MA0103.11.29536
MA0105.10.232357
MA0106.10.869173
MA0107.10.453492
MA0108.21.03412
MA0109.10
MA0111.10.655276
MA0113.10.886811
MA0114.10.447443
MA0115.11.45393
MA0116.15.2233
MA0117.11.24497
MA0119.10.586221
MA0122.11.27173
MA0124.11.41151
MA0125.11.32534
MA0130.10
MA0131.10.94608
MA0132.10
MA0133.10
MA0135.11.23748
MA0136.10.832277
MA0139.10.912459
MA0140.10.779643
MA0141.10.602484
MA0142.11.00381
MA0143.10.887001
MA0144.10.430413
MA0145.11.08195
MA0146.12.31379
MA0147.10.46175
MA0148.10.739888
MA0149.10.769072
MA0062.20.353589
MA0035.20.778873
MA0039.22.52211
MA0138.20.928035
MA0002.20.379056
MA0137.20.558189
MA0104.20.392359
MA0047.20.856092
MA0112.20.551048
MA0065.20.577908
MA0150.10.633493
MA0151.10
MA0152.10.78681
MA0153.11.30799
MA0154.10.229241
MA0155.11.02191
MA0156.10.560797
MA0157.10.97481
MA0158.10
MA0159.10.462502
MA0160.10.756582
MA0161.10
MA0162.11.06783
MA0163.11.37853
MA0164.10.90014
MA0080.20.535868
MA0018.20.870662
MA0099.20.7872
MA0079.27.00686
MA0102.21.75932
MA0258.10.418966
MA0259.10.471671
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.